Literature DB >> 26115671

Junctional abnormalities in human airway epithelial cells expressing F508del CFTR.

Samuel A Molina1, Brandon Stauffer2, Hannah K Moriarty3, Agnes H Kim3, Nael A McCarty2, Michael Koval4.   

Abstract

Cystic fibrosis (CF) has a profound impact on airway physiology. Accumulating evidence suggests that intercellular junctions are impaired in CF. We examined changes to CF transmembrane conductance regulator (CFTR) function, tight junctions, and gap junctions in NuLi-1 (CFTR(wt/wt)) and CuFi-5 (CFTR(ΔF508/ΔF508)) cells. Cells were studied at air-liquid interface (ALI) and compared with primary human bronchial epithelial cells. On the basis of fluorescent lectin binding, the phenotype of the NuLi-1 and CuFi-5 cells at week 8 resembled that of serous, glycoprotein-rich airway cells. After week 7, CuFi-5 cells possessed 130% of the epithelial Na(+) channel activity and 17% of the CFTR activity of NuLi-1 cells. In both cell types, expression levels of CFTR were comparable to those in primary airway epithelia. Transepithelial resistance of NuLi-1 and CuFi-5 cells stabilized during maturation in ALI culture, with significantly lower transepithelial resistance for CuFi-5 than NuLi-1 cells. We also found that F508del CFTR negatively affects gap junction function in the airway. NuLi-1 and CuFi-5 cells express the connexins Cx43 and Cx26. While both connexins were properly trafficked by NuLi-1 cells, Cx43 was mistrafficked by CuFi-5 cells. Cx43 trafficking was rescued in CuFi-5 cells treated with 4-phenylbutyric acid (4-PBA), as assessed by intracellular dye transfer. 4-PBA-treated CuFi-5 cells also exhibited an increase in forskolin-induced CFTR-mediated currents. The Cx43 trafficking defect was confirmed using IB3-1 cells and found to be corrected by 4-PBA treatment. These data support the use of NuLi-1 and CuFi-5 cells to examine the effects of F508del CFTR expression on tight junction and gap junction function in the context of serous human airway cells.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  air-liquid culture; cell model; connexin; cystic fibrosis; differentiation; gap junction; normal lung

Mesh:

Substances:

Year:  2015        PMID: 26115671      PMCID: PMC4556929          DOI: 10.1152/ajplung.00060.2015

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  68 in total

1.  Lectin binding and endocytosis at the apical surface of human airway epithelia.

Authors:  S M Yi; R E Harson; J Zabner; M J Welsh
Journal:  Gene Ther       Date:  2001-12       Impact factor: 5.250

2.  DNA-triggered innate immune responses are propagated by gap junction communication.

Authors:  Suraj J Patel; Kevin R King; Monica Casali; Martin L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

3.  Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.

Authors:  C P Morales; S E Holt; M Ouellette; K J Kaur; Y Yan; K S Wilson; M A White; W E Wright; J W Shay
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

Review 4.  Claudin heterogeneity and control of lung tight junctions.

Authors:  Michael Koval
Journal:  Annu Rev Physiol       Date:  2012-10-15       Impact factor: 19.318

Review 5.  Connexins in respiratory and gastrointestinal mucosal immunity.

Authors:  Joanna Bou Saab; Davide Losa; Marc Chanson; Richard Ruez
Journal:  FEBS Lett       Date:  2014-03-12       Impact factor: 4.124

6.  Chromosomal instability causes sensitivity to metabolic stress.

Authors:  Z Shaukat; D Liu; A Choo; R Hussain; L O'Keefe; R Richards; R Saint; S L Gregory
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

7.  ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.

Authors:  Laurence Suaud; Katelyn Miller; Lora Alvey; Wusheng Yan; Amal Robay; Catherine Kebler; James L Kreindler; Susan Guttentag; Michael J Hubbard; Ronald C Rubenstein
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

Review 8.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

9.  The effects of the histone deacetylase inhibitor 4-phenylbutyrate on gap junction conductance and permeability.

Authors:  Joshua Kaufman; Chris Gordon; Roberto Bergamaschi; Hong Z Wang; Ira S Cohen; Virginijus Valiunas; Peter R Brink
Journal:  Front Pharmacol       Date:  2013-09-03       Impact factor: 5.810

10.  Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43.

Authors:  M Koval; S T Geist; E M Westphale; A E Kemendy; R Civitelli; E C Beyer; T H Steinberg
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

View more
  27 in total

Review 1.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

2.  Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.

Authors:  Brahmchetna Bedi; Nicholas M Maurice; Vincent T Ciavatta; K Sabrina Lynn; Zhihong Yuan; Samuel A Molina; Myungsoo Joo; William R Tyor; Joanna B Goldberg; Michael Koval; C Michael Hart; Ruxana T Sadikot
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

3.  Insulin signaling via the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier function in a CFTR-dependent manner.

Authors:  Samuel A Molina; Hannah K Moriarty; Daniel T Infield; Barry R Imhoff; Rachel J Vance; Agnes H Kim; Jason M Hansen; William R Hunt; Michael Koval; Nael A McCarty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-17       Impact factor: 5.464

Review 4.  Ion channels of the lung and their role in disease pathogenesis.

Authors:  Rafal Bartoszewski; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-12       Impact factor: 5.464

Review 5.  Stem cell-derived organoids to model gastrointestinal facets of cystic fibrosis.

Authors:  Meike Hohwieler; Lukas Perkhofer; Stefan Liebau; Thomas Seufferlein; Martin Müller; Anett Illing; Alexander Kleger
Journal:  United European Gastroenterol J       Date:  2016-09-21       Impact factor: 4.623

Review 6.  Mucosal Immunity in Cystic Fibrosis.

Authors:  Christine M Bojanowski; Shiping Lu; Jay K Kolls
Journal:  J Immunol       Date:  2021-12-15       Impact factor: 5.426

7.  A physiologically-motivated model of cystic fibrosis liquid and solute transport dynamics across primary human nasal epithelia.

Authors:  Florencio Serrano Castillo; Carol A Bertrand; Michael M Myerburg; Monica E Shapiro; Timothy E Corcoran; Robert S Parker
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-09-07       Impact factor: 2.745

8.  Lung function of primary cooks using LPG or biomass and the effect of particulate matter on airway epithelial barrier integrity.

Authors:  Emma M Stapleton; Abhilash Kizhakke Puliyakote; Nervana Metwali; Matthew Jeronimo; Ian M Thornell; Robert B Manges; Monalisa Bilas; Mohamed Ali Kamal Batcha; Mangaleswari Seeniappan Kumaravel; Kumar Durairaj; Kesavan Karuppusamy; Geetha Kathiresan; Sirajunnisa Abdul Rahim; Kumaran Shanmugam; Peter S Thorne; Thomas M Peters; Eric A Hoffman; Alejandro P Comellas
Journal:  Environ Res       Date:  2020-07-15       Impact factor: 6.498

9.  Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.

Authors:  Eleonore Fröhlich
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Bacteriophage-Loaded Poly(lactic-co-glycolic acid) Microparticles Mitigate Staphylococcus aureus Infection and Cocultures of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Pranav P Kalelkar; Dina A Moustafa; Milan Riddick; Joanna B Goldberg; Nael A McCarty; Andrés J García
Journal:  Adv Healthc Mater       Date:  2022-01-07       Impact factor: 11.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.